Stock listing
Zentalis Pharmaceuticals, Inc.
Selected listing: ZNTL · NASDAQ · USD · US
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL), Health Technology. Latest release Oct 1, 2026: Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq…
- Ticker
- NASDAQ:ZNTL
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Zentalis Pharmaceuticals, Inc.
Zentalis Pharmaceuticals, Inc. is a public company traded under the ticker ZNTL in the American market. Zentalis focuses on developing innovative therapies for cancer treatment.
Latest news from Zentalis Pharmaceuticals, Inc.
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 30, 2026
Zentalis Pharmaceuticals Announces Closing of Underwritten Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
August 18, 2026
Zentalis Pharmaceuticals Announces Closing of Underwritten Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
August 17, 2026
Zentalis Pharmaceuticals Announces Proposed Underwritten Public Offering
August 13, 2026
Zentalis Pharmaceuticals Announces Pricing of Underwritten Public Offering
August 12, 2026
Research Zentalis Pharmaceuticals, Inc.
Zentalis Pharmaceuticals, Inc. company profile
View the public company page for Zentalis Pharmaceuticals, Inc. on 6ix.
Zentalis Pharmaceuticals, Inc. news
Read company news and market updates connected to Zentalis Pharmaceuticals, Inc..
Zentalis Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Zentalis Pharmaceuticals, Inc..